GNMSF Financials
Genmab A/S - Financial statements & key metrics
Stock Price
$330.37
Market Cap
$20.35B
P/E Ratio
14.5
EPS
$22.83
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$21.53B
Gross Profit
$20.54B
Operating Income
$6.70B
Net Income
$7.84B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$45.81B
Total Liabilities
$9.11B
Shareholders Equity
$36.70B
Cash & Equivalents
$9.86B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$7.77B
CapEx
$187.00M
Free Cash Flow
$7.58B
Profitability Metrics
Gross Margin
94.4%
Operating Margin
0.4%
Net Margin
0.4%
ROE
0.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is GNMSF revenue?
GNMSF's most recent quarterly revenue was $21.53B. Annual revenue can be calculated by summing the four most recent quarters.
Is GNMSF profitable?
GNMSF reported a profit of $7.84B in the most recent quarter. The net profit margin is 0.4%.
What is GNMSF market cap?
GNMSF has a market capitalization of $20.35B, making it a large-cap stock.
Does GNMSF have debt?
View GNMSF's balance sheet for debt information.
What is GNMSF cash flow?
GNMSF's most recent quarterly free cash flow was $7.58B.